Research Article
Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD
Table 2
Diagnostic power of eosinophil-associated cytokines as markers differentiating active UC from CD.
(a) |
| Marker | AUC (95% CI), AUC = 0.5 | Cut-off | Sens.&Spec. | index |
| Eotaxin | 0.708 (0.62–0.78), | >138 pg/ml | 71 and 68% | 0.391 | IL13 | 0.604 (0.52–0.69), | >20.8 pg/ml | 51 and 69% | 0.203 | IFNγ | 0.594 (0.51–0.68), | >64.5 pg/ml | 76 and 44% | 0.199 | hsCRP | 0.657 (0.57–0.74), | ≥19.9 mg/l | 74 and 60% | 0.347 |
|
|
(b) |
| Panel | AUC (95% CI) | Difference | Learning set | Validation set | statistics, |
| Eotaxin, hsCRP, IFNγ | 0.78 (0.7–0.87) | 0.73 (0.63–0.82) | 0. 818, |
|
|
hsCRP was tested as an indicator of CD. AUC: area under ROC curve; Sens.&Spec.: sensitivity and specificity; index: Youden index. |